How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BS

OOTC:BSYI
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BS

BioSyntech IncOOTC BSYI Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is BSYI undervalued compared to its fair value?

The fair value of BSYI stock is hidden USD. Relative to the market price of 0.003 USD BioSyntech Inc is hidden.

BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. The company is headquartered in Laval, Quebec and currently employs 20 full-time employees. The company w...[More about valuation]

BioSyntech Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

Price:

0.003 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

STOCK ANALYSIS

Is BSYI attractive for investment based on fundamental analysis?

BSYI stock rating is hidden. BioSyntech is a hidden by Eyestock methodology.

Get BSYI Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BSYI analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BSYI to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

BioSyntech Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

BioSyntech Inc dividends

BSYI dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BSYI stock

About the company BioSyntech Inc

Market cap $B

Dividend yield

Shares outstanding

116.44 B

Website

BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. The company is headquartered in Laval, Quebec and currently employs 20 full-time employees. The company went IPO on 2000-01-10. The firm is developing biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. The firm's platform technology is a family of hydrogels called BST-Gel, some of which are liquid at low temperature and solid at human body temperature. These gels can be injected or applied to a specific local site and offers properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds and provide the benefit of avoiding invasive surgery. The firm's lead, late-stage product, BST-CarGel is undergoing an international pivotal trial.

BSYI profile

  • Ticker

    BSYI

  • Country

    Canada

  • Exchange

    OOTC - OTC

  • Report currency

    CAD - Canadian dollar

  • IPO date

    10 January 2000

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    20

  • City

    Laval

  • Address

    475 Armand-Frappier Blvd.

  • Cusip

    09068L103